Ugo Gay - DiaSorin SpA Sr Operations
| DSRLF Stock | USD 109.60 9.34 9.32% |
Insider
Ugo Gay is Sr Operations of DiaSorin SpA
| Age | 58 |
| Phone | 39 01 614871 |
| Web | https://diasoringroup.com |
DiaSorin SpA Management Efficiency
The company has return on total asset (ROA) of 0.0902 % which means that it generated a profit of $0.0902 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.198 %, meaning that it generated $0.198 on every $100 dollars invested by stockholders. DiaSorin SpA's management efficiency ratios could be used to measure how well DiaSorin SpA manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Padraig McDonnell | Agilent Technologies | 53 | |
| Georgeann Couchara | Danaher | 48 | |
| Michael Petras | Sotera Health Co | 56 | |
| Dr MBA | ICON PLC | 65 | |
| Scott Ericksen | Illumina | 52 | |
| Eric Evans | Natera Inc | N/A | |
| Erin Smith | Twist Bioscience Corp | N/A | |
| Oliver Wittorf | Mettler Toledo International | N/A | |
| Pearl Huang | Waters | 62 | |
| Belinda Hyde | Waters | 53 | |
| Joseph Holmes | Thermo Fisher Scientific | 45 | |
| Keeley Aleman | Waters | 47 | |
| Jeffrey Spaeder | IQVIA Holdings | N/A | |
| Sandy Pound | Thermo Fisher Scientific | N/A | |
| Darlene Solomon | Agilent Technologies | 65 | |
| Domitille Bigot | Mettler Toledo International | 48 | |
| John Ballbach | Waters | 60 | |
| Niamh Murphy | ICON PLC | N/A | |
| Syed Jafry | Thermo Fisher Scientific | 56 | |
| Kevin Yankton | Twist Bioscience Corp | 57 | |
| Kumud Kalia | Guardant Health | 59 | |
Management Performance
| Return On Equity | 0.2 | |||
| Return On Asset | 0.0902 |
DiaSorin SpA Leadership Team
Elected by the shareholders, the DiaSorin SpA's board of directors comprises two types of representatives: DiaSorin SpA inside directors who are chosen from within the company, and outside directors, selected externally and held independent of DiaSorin. The board's role is to monitor DiaSorin SpA's management team and ensure that shareholders' interests are well served. DiaSorin SpA's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, DiaSorin SpA's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Fabrizio Bonelli, Chief Officer | ||
| Carlo Rosa, CEO, General Manager and Executive Director | ||
| Piergiorgio Pedron, Senior Corporate VP and CFO | ||
| Ulisse Spada, Mang Department | ||
| Angelo Rago, Pres Corp | ||
| Stefano Ronchi, Sr. Corporate VP of HR | ||
| Ugo Gay, Sr Operations | ||
| Chen Even, Chief Commercial Officer and Executive Director | ||
| Riccardo Fava, Director of Investor Relations and Corporate Communication |
DiaSorin Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is DiaSorin SpA a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.2 | |||
| Return On Asset | 0.0902 | |||
| Profit Margin | 0.20 % | |||
| Operating Margin | 0.29 % | |||
| Current Valuation | 8.64 B | |||
| Shares Outstanding | 53.84 M | |||
| Shares Owned By Insiders | 57.50 % | |||
| Shares Owned By Institutions | 22.36 % | |||
| Price To Earning | 26.36 X | |||
| Price To Book | 4.73 X |
Currently Active Assets on Macroaxis
Other Information on Investing in DiaSorin Pink Sheet
DiaSorin SpA financial ratios help investors to determine whether DiaSorin Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in DiaSorin with respect to the benefits of owning DiaSorin SpA security.